Patents by Inventor Tatsuya KAWAMOTO

Tatsuya KAWAMOTO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109503
    Abstract: The present disclosure relates to an attachment structure for attaching a wiring member to an instrument panel reinforcement, which is an attachment object, provided near an instrument panel. The wiring member includes a linear transmission member that transmits electricity or light, and a covering member that covers the linear transmission member. The wiring member attachment structure includes a rail member provided on the instrument panel reinforcement, and an insertion member that is provided on the covering member and inserted into the rail member. The wiring member is attached to the instrument panel reinforcement in a state in which the insertion member is inserted into the rail member.
    Type: Application
    Filed: September 27, 2023
    Publication date: April 4, 2024
    Applicants: SUMITOMO WIRING SYSTEMS, LTD., TOYOTA JIDOSHA KABUSHIKI KAISHA, KABUSHIKI KAISHA TOYOTA JIDOSHOKKI
    Inventors: Tatsumi SATO, Kazuhiro Nishimura, Hirozumi Okaniwa, Tomohiko Tateishi, Tatsuya Aida, Yuji Kawamoto
  • Patent number: 11746332
    Abstract: A method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. The high-purity renal progenitor cells can be used in regenerative medicine for renal diseases, such as renal failure.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: September 5, 2023
    Assignees: Astellas Pharma Inc., Kyoto University
    Inventors: Tatsuya Kawamoto, Yukiko Yamagishi, Kenji Osafune
  • Patent number: 11485635
    Abstract: A hydrogen generator having a reforming catalyst that causes hydrocarbon gas and steam to carry out a reforming reaction and reform into a hydrogen rich reformed gas, a reformer that is filled with said reforming catalyst and in which said reforming reaction is carried out, and a combustion chamber for combusting a fuel gas and obtaining reaction heat that is applied to said reforming reaction. At least the reforming region carrying out the reforming reaction is disposed inside the combustion chamber. A steam generator that introduces steam into the reformer is provided outside the combustion chamber.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: November 1, 2022
    Assignee: Air Water Inc.
    Inventors: Tatsuya Kawamoto, Masako Tanaka, Yoshiro Nitta, Shinya Kawahara
  • Publication number: 20200407692
    Abstract: A method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. The disclosed method may include, for example, the steps of: (i) culturing the pluripotent stem cells under conditions that induce differentiation into renal progenitor cells; and (ii) sorting a cell population from the cells obtained at step (i), by using at least one cell surface marker selected from the group consisting of CD9(?), CD55(?), CD106(+), CD140a(+), CD140b(+), CD165(+), CD271(+) and CD326(?).
    Type: Application
    Filed: June 25, 2020
    Publication date: December 31, 2020
    Applicants: Astellas Pharma Inc., KYOTO UNIVERSITY
    Inventors: Tatsuya Kawamoto, Yukiko YAMAGISHI, Kenji OSAFUNE
  • Publication number: 20200283294
    Abstract: A hydrogen generator having a reforming catalyst that causes hydrocarbon gas and steam to carry out a reforming reaction and reform into a hydrogen rich reformed gas, a reformer that is filled with said reforming catalyst and in which said reforming reaction is carried out, and a combustion chamber for combusting a fuel gas and obtaining reaction heat that is applied to said reforming reaction. At least the reforming region carrying out the reforming reaction is disposed inside the combustion chamber. A steam generator that introduces steam into the reformer is provided outside the combustion chamber.
    Type: Application
    Filed: October 26, 2018
    Publication date: September 10, 2020
    Inventors: Tatsuya KAWAMOTO, Masako TANAKA, Yoshiro NITTA, Shinya KAWAHARA
  • Patent number: 10731133
    Abstract: A method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. The disclosed method may include, for example, the steps of: (i) culturing the pluripotent stem cells under conditions that induce differentiation into renal progenitor cells; and (ii) sorting a cell population from the cells obtained at step (i), by using at least one cell surface marker selected from the group consisting of CD9(?), CD55(?), CD106(+), CD140a(+), CD140b(+), CD165(+), CD271(+) and CD326(?).
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: August 4, 2020
    Assignees: Astellas Pharma Inc., Kyoto University
    Inventors: Tatsuya Kawamoto, Yukiko Yamagishi, Kenji Osafune
  • Publication number: 20180273905
    Abstract: An object of the present invention resides in providing a method for acquiring and producing high-purity renal progenitor cells from a renal progenitor cell population into which pluripotent stem cells are induced to differentiate, by identifying a cell surface antigen marker specific to renal progenitor cells. A method for producing renal progenitor cells into which pluripotent stem cells are induced to differentiate, the method comprising the steps of: (i) culturing the pluripotent stem cells under conditions that induce differentiation into renal progenitor cells; and (ii) sorting a cell population from the cells obtained at step (i), by using at least one cell surface marker selected from the group consisting of CD9(?), CD55(?), CD106(+), CD140a(+), CD140b(+), CD165(+), CD271(+) and CD326(?).
    Type: Application
    Filed: September 9, 2016
    Publication date: September 27, 2018
    Applicants: Astellas Pharma Inc., KYOTO UNIVERSITY
    Inventors: Tatsuya KAWAMOTO, Yukiko YAMAGISHI, Kenji OSAFUNE